Release  date:     June 15, 2022  
  Expiration  date:   June 15, 2025  
Estimated Time of Completion: 1 hour
		Description
        				Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
			  
	
		
Learning Objectives
	
    
	
	
    After  completing this case the reader should be able to:
  - List the adverse events associated with glucocorticoid use  and describe their importance in clinical practice.
- Summarize dosing regimens for glucocorticoids and describe  their impact on adverse events.
- Implement practices to risk assess, prevent, and treat  glucocorticoid adverse events.  
- Counsel patients regarding the adverse events associated with  glucocorticoid use and their effect on patient adherence.
 
	 
 
	
		
Target Audience
	
	
	
		Directed to primary care physicians including family practitioners and internists.
 
	 
 
	
		
Accreditation
	
	
	
        
In support of improving patient care,  Cleveland Clinic Center for Continuing Education is jointly accredited by the  Accreditation Council for Continuing Medical Education (ACCME), the  Accreditation Council for Pharmacy Education (ACPE), and the American Nurses  Credentialing Center (ANCC), to provide continuing education for the healthcare  team.
American Medical Association (AMA) 
  Cleveland Clinic Foundation Center for  Continuing Education designates this enduring activity for a maximum  of 1.0 AMA PRA Category  1 Credits™. Physicians should claim only the credit commensurate  with the extent of their participation in the activity.
Participants claiming CME credit from  this activity may submit the credit hours to the American Osteopathic  Association for Category 2 credit.
Successful  completion of this CME activity, which includes participation in the evaluation  component, enables the participant to earn up to the following boards:
ABA MOC:  American Board of  Anesthesiology (ABA) 1.0  Lifelong Learning MOC points in the ABA MOCA  2.0® Maintenance of Certification in Anesthesiology Program®
ABIM  MOC: American Board of Internal Medicine (ABIM) 1.0 Medical Knowledge ABIM MOC  points in the ABIM MOC Assessment Recognition Program.
 
ABOHNS CC:   
  American Board of Otolaryngology-Head and Neck Surgery  (ABOHNS) 1.0 Lifelong Learning (Part II) MOC Points.
ABPath MOC:   
  American Board of Pathology (ABPath) 1.0  Lifelong Learning credits in the ABPath Continuing Certification Program
 
ABP MOC:  American  Board of Pediatrics (ABP) 1.0 Lifelong Learning & Self-Assessment MOC  points in the ABP Maintenance of Certification Program.
 ABS  MOC: American Board of Surgery (ABS) 1.0 Accredited  CME credits toward ABS Continuous Certification Program
Credit will be reported within 30 days  of claiming credit
        
         
	 
 
	
		
Activity Director and Faculty
	
	
	
    		Activity Director
	Anthony Fernandez, MD, PhD
	 Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Medical Co-Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH
	
        
Steven Kawczak, PhD, CHCP, FACEHP
  Assistant Professor of Medicine, Cleveland  Clinic Lerner College of Medicine of CWRU
  Co-Director, Center for Continuing Education
  Staff, Center for Educational Resources
  Education Institute
  Cleveland  Clinic
  Cleveland,  OH
        
        
	Faculty
Adam Brown, MD
Department of Rheumatologic and Immunologic Disease
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
	 
	 
 
	
		
CME Disclaimer
	
	
	
    	The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
 
	 
 
Disclosures
	In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
    The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
				
  
    | Adam J Brown, MD | 
  
    | Chemocentryx  | ConsultingTeaching and Speaking
 | 
                
  
    | Anthony Fernandez, MD | 
  
    | Bristol-Myers      Squibb Co., UCB, Inc. | Consulting | 
  
    | Pfizer, Inc. | Research /      Independent Contractor | 
  
    | Mallinckrodt      Inc., Novartis | ConsultingResearch / Independent Contractor
 Teaching and Speaking
 | 
  
    | Abbvie      Pharmaceuticals | ConsultingResearch / Independent Contractor
 Advisor or review panel participant
 Teaching and Speaking
 | 
  
    | Kyowa Kirin | Teaching and      Speaking | 
        
 
                
                
			
		
 The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Steven Kawczak, PhD 
 
				
 
This CME activity was produced by The Cleveland Clinic
  Center for Continuing Education.